Depemokimab: a new biologic for eosinophilic asthma The NHS BSA has added depemokimab to the dm+d dictionary (version 6.0.0). This is a monoclonal antibody that targets the interleukin-4 receptor, used to treat moderate-to-severe eosinophilic asthma in patients with elevated blood eosinophils (≥300 cells/μL). What is depemokimab used for? Depemokimab is a biologic immunosuppressant given by […]
Amphotericin B phospholipid complex added to NHS dm+d — event medicine essentials
Amphotericin B phospholipid complex: new to dm+d The NHS Business Services Authority has added Amphotericin B phospholipid complex to the dm+d dictionary (version 5.0.0). This is a polyene antifungal used to treat serious systemic fungal infections in hospital and specialist care settings. What is it used for? Amphotericin B phospholipid complex is indicated for: Invasive […]
Candesartan + Hydrochlorothiazide added to NHS dm+d — event medicine guidance
New moiety: Candesartan + Hydrochlorothiazide The NHS BSA has added Candesartan + Hydrochlorothiazide to the dm+d dictionary (version 5.0.0). This is a fixed-dose combination of an angiotensin II receptor antagonist and a thiazide diuretic, used to manage chronic hypertension in patients already stabilised on both components. What is it used for? Candesartan + Hydrochlorothiazide is […]